Nr283 Exam 3 Studyguide
NR283 EXAM 3 STUDYGUIDE CHAPTER 18 ENDOCRINE All right guys here is endocrine! Overview- functions of the endocrine system provide growth & reproductive capabilities. Dysfunction of the endocrine system includes excessive or insufficient function of the endocrine gland with alterations in hormone levels caused by either hypersecretion or hyposecretion of hormone abnormal hormone levels. Dysfunction of an endocrine gland can also be due to: 1) feedback systems failure to function or respond to inappropriate signals, 2) decreased hormone delivery caused by inadequate blood supply to the gland or target tissues, or an insufficient amount of the appropriate carrier proteins in the serum. Ectopic sources of hormones (hormones produced by nonendocrine tissues) may cause abnormally elevated hormone levels w/o the benefit of normal feedback system for hormone controls---ectopic production is autonomous. Look at (Table 18-1) Diseases of the Posterior Pituitary: Related to abnormal secretion of ADH. An excess of this hormone results in water retention and a hypoosmolar state, whereas deficiencies in the amount or response to ADH result in serum hyperosmolarity. 1) Syndrome of inappropriate ADH secretion (SIADH), also known as vasopressin dysregulation, occurs with high levels of ADH without normal physiologic stimuli for release. Most common cause is the ectopic production of ADH by tumors such as small cell carcinoma of the duodenum, stomach, and pancreas, bladder, prostate and endometrium CA, lymphomas, and sarcomas. Pulmonary disorders: bronchogenic carcinoma, pneumonia, asthma, cystic fibrosis, and respiratory failure requiring mechanical vent. CNS disorders: encephalitis, meningitis, intracranial hemorrhage, tumors and trauma. Surgery can result in increased ADH secretion. This is related to fluid and volume changes, the amount and type of IV fluids given and narcotic analgesics. Examples of medication causes include: hypoglycemic meds, narcotics, general anesthetics, chemo agents, NSAIDs, synthetic ADH analogs. PATHO: Enhanced water retention. ADH increases renal collecting duct permeability to water by inducing the insertion of (aquaporin-2), a water channel protein, into the tubular luminal membrane---increasing water reabsorption by the kidneys. Resulting in expansion of extracellular fluid volume----dilutional hyponatremia, hypoosmolarity, and urine is inappropriately concentrated with respect to serum osmaolarity. CLINICAL MANIFESTATION: * Thirst, ● impaired taste, ● anorexia, ● dyspnea on exertion (DOE), ● fatigue and dulled sensorium all due to hyponatremia. ● Vomiting, abd cramping (130-120 NA level). ● Levels below 110=confusion, lethargy, muscle twitching, convulsions, irreversible neurologic damage. 2) Diabetes Insipidus: Insufficient activity of ADH leading to polyuria and polydipsia. 2 Forms include: 1) Neurogenic or central DI- insufficient secretion of ADH occurring when any organic lesion of the hypothalamus, pituitary stalk, or posterior pituitary interferes with ADH synthesis, transport or release. Lesions include primary brain tumors, hypophysectomy, aneurysms, thrombosis, infections, and immunologic disorders, closed head injury. Also caused by hereditary disorders affecting ADH genes or structural changes in the pituitary gland. 2) Nephrogenic DI: inadequate response of the renal tubules to ADH, usually acquired or genetic. Acquired: disorders and drugs that damage the renal tubules or inhibit the generation of cAMO in the tubules. Disorders include, pyelonephritis, amyloidosis, destructive uropathies, polycystic kidney disease---all leading to irreversible diabetes insipidus. Drugs: lithium carbonate, colchicines, amphotericin B, loop diuretics, general anesthetics and demeclocycline. Genetic: mutation in the gene that codes for aquaporin-2. PATHO: Partial/total inability to concentrate urine. Insufficient ADH activity causes excretion of large volumes of dilute urine----increased plasma osmolality. CLINICAL MANIFESTATIONS: * Polyuria, Nocturia, Continued thirst, polydipsia, hydronephrosis. DIABETES MELITUS: Metabolic disease, defect in insulin secretion. ● Diagnosis based on HbA1C levels: Glycosylated hemoglobin is a form of hemoglobin that is measured primarily to identify three-month average plasma glucose concentration. DIABETES TYPE I: Most common among pediatrics. PATHO: Autoimmune T-cell mediated disease that destroys beta cells of the pancreas. Destruction of beta cells is related to genetic susceptibility and environmental factors. Strongest genetic association is with histocompatibility leukocyte antigen (HLA). Environmental factors=exposure to certain drugs, foods and viruses. Cellular immunity and humoral immunity are stimulated, resulting in beta-cell destruction and apoptosis. Insulin synthesis declines=hyperglycemia. Insulin-secreting beta cells of the islet of Langerhans must be destroyed. Glucagon, a hormone produced by the alpha cells of the islets, acts in the liver to increase blood glucose level by stimulating glycogenolysis and glucogenesis. In addition to decline in insulin secretion---decreased secretion of amylin (beta-cell hormone). Amylin suppresses glucagon release from the alpha cells. Thus both alpha-call and beta-cell functions are abnormal and both a lack of insulin and a relative excess of glucagon contribute to hyperglycemia. CLINICAL MANIFESTATIONS: Affects fat, protein and carb metabolism. (TABLE 18-5)! ● polyuria ● polydipsia 3P’s ● polyphagia ● Thirst ● Weight loss ● DKA ● Fatigue ● Visual changes DIABETES TYPE II: (non-insulin dependent) Risk factors: age, obesity, hypertension, physical activity and family history. Individuals with metabolic syndrome (obesity, dyslipidemia, prehypertension, and hyperglycemia). PATHO: Insulin resistance and decreased insulin secretion by beta cells. Insulin resistance- suboptimal response of insulin-sensitive tissues to insulin and assoc with obesity. Mechanisms of obesity: 1) obesity results in increased serum levels of leptin and decreased levels of adiponectin. These changes associated with inflammation and decreased insulin sensitivity. 2) elevated levels of serum free fatty acids and intracellular deposits of triglycerides and cholesterol interfering with intracellular insulin signaling and decreases tissue responses to insulin and contribute to beta-cell apoptosis. 3) inflammatory cytokines and interleukin-6 are released and induce insulin resistance and are cytotoxic to beta cells. 4) obesity is correlated with hyperinsulinemia and decreased insulin receptor density. LOOK AT FIG 18-12! ● Beta-cell dysfunction develops and leads to a relative deficiency of insulin activity. The islet dysfunction is caused by a combination of a decrease in beta-cell mass and reduction in normal beta-cell function. ● Glucagon concentration is increased due to pancreatic alpha cells becoming less responsive to glucose inhibition increase in glucagon secretion. These high levels of glucagon increase blood glucose level by stimulating glycogenolysis and gluconeogenesis. ● Hormones released from GI tract play a role in insulin resistance, beta-cell function. (Gherlin) CLINICAL MANIFESTATIONS: * overweight * dyslipidemic ● hyperinsulinemic ● hypertensive ● polyuria ● polydipsia ● fatigue ● pruritus ● recurrent infections ● visual changes ● neuropathy symptoms ACUTE COMPLICATIONS OF DIABETES MELLITUS 3 Major Acute complications: 1) Hypoglycemia: (insulin shock or insulin reaction) more common in type 1 DM. Symptoms: pallor, tremor, anxiety, tachycardia, palpitations, diaphoresis, headache, dizziness, irritability, fatigue, poor judgement, confusion, visual disturbances, hunger, seizures, and coma. 2) Diabetic Ketoacidosis (DKA): SERIOUS complication related to a deficiency of insulin and an increase in the levels of insulin counterregulatory hormones (catecholamines, cortisol, glucagon, growth hormone). More common in type I because insulin is more deficient. DX criteria: 1) serum glucose level 250, 2) serum bicarb level 18, 3) serum Ph 7.30, 4) presence of anion gap, and 5) presence of urine and serum Insulin deficiency enhances lipolysis therefore; increasing amount of nonesterfied fatty acids delivered to the liver. This results in increased glyconeogenesis which contributes to hyperglycemia and production of ketones bodies by mitochondria of the liver at a rate that exceeds peripheral use. Accumulation of ketone bodies causes drop in pHmetabolic acidosis. 3) Hyperosmolar hyperglycemic nonketotic syndrome (HHNKS): Sig complication of type II, occurring more often in elderly with infections or cardiovascular or renal disease. **differs from DKA in the degree of insulin deficiency and the degree of fluid deficiency*** Clinical Features: 1) serum glucose level 600, 2) serum Ph 7.30, 3) serum bicarb level 15, 4) serum osmolarity 320, 5) either absent or small numbers of ketones in the urine and serum. Somogyi effect: combination of hypoglycemia followed by rebound hyperglycemia. Dawn phenomenon: early morning rise in blood glucose with no hypoglycemia during the night. Nocturnal elevations of GH, which decrease metabolism of glucose by muscle and fat. CHRONIC COMPLICATIONS OF DM: Microvascular Disease: Diabetic retinopathy- leading cause of blindness. Results from relative hypoxemia, damage to retinal blood vessels and RBC aggregation. Diabetic nephropathy- end-stage kidney disease. Microalbuminuria is the first manifestation of kidney dysfunction. Diabetic neuropathy- metabolic and vascular factors related to chronic hyperglycemia with ischemia and demyelination contributing to neural changes. Sensory deficits are more common than motor involvement and often involve the extremities first. Macrovascular Disease: A) Coronary Artery disease: hyperglycemia and insulin resistance, high levels of LDL and triglycerides, low levels of HDL, platelet abnormalities and endothelial cell dysfunction. B) Stroke: Hypertension, hyperglycemia, hyperlipidemia and thrombosis. C) Peripheral vascular disease: Usually involves arteries below the knees. Occlusions of small arteries and arterioles cause most of the gangrenous changes of the lower extermities. Lesions begin as ulcers and progress to osteomyelitis or gangrene---amputation. Infections: Due to impaired senses which lead to loss of protection to injury. Hypoxia-compromised skin integrity, tissue’s susceptibility to infection increases as a result of hypoxia. Pathogens-proliferate rapidly due to increased glucose in body fluids, providing excellent source of energy. Blood supply-decrease WBC to affected area due to decreased blood supply from vascular changes. Suppressed immune response-chronic hyperglycemia impairs both innate and adaptive immune responses. DISEASES OF THE ANTERIOR PITUITARY Hypopituitarism: results from either an inadequate supply of hypothalamic-releasing hormones, because of damage to the pituitary stalk, or an inability of the gland to produce hormones. The most common causes lie within the pituitary gland itself and result from pituitary infarction or space-occupying lesions, such as pituitary adenomas or aneurysms. Other causes include: removal or destruction of the gland, head trauma, infections (meningitis, syphilis, tb), autoimmune hypophysitis, certain drugs, or mutation of the prophet of pituitary transcription factor gene involved in early embryonic pituitary development. PATHO: The pituitary gland is highly vascular and relies heavily upon portal blood flow from the hypothalamus, therefore; vulnerable to ischemia and infarction. Infarction may be seen with Sheehan syndrome (postpartum pituitary necrosis), pituitary apoplexy, traumatic brain injury, shock, sickle cell disease, and DM. Infarction results in tissue necrosis and edema with swelling of the gland. Expansion of the pituitary within the fixed compartment of the sella turcica further impedes blood supply. Over time there is shrinkage and fibrosis of tissue and symptoms develop. Adenomas and aneurysms compress otherwise normal secreting pituitary cells and lead to compromised hormonal output. CLINICAL MANIFESTATIONS: Panhypopituitarism-all hormones are deficient and ind. Suffers multiple complications including: cortisol deficiency from lack of ACTH, thyroid deficiency from lack of TSH, and loss of secondary sex characteristics bc lack of FSH and LH. Low levels of GH and IGF-1 affect growth in children and cause physiologic and psychologic symptoms in adults. Hyperpituitarism: Primary adenomas are usually benign, slow-growing that arise from cells of the anterior pituitary. PATHO: Expansion of the adenoma may impinge on the optic chiasma-causing visual disturbances. Locally aggressive tumor causes invasion of the cavernous sinuses compromising oculomotor, trochlear, abducens and trigeminal nerves. Extension to the hypothalamus disturbs control of wakefulness, thirst, appetite and temperature. Hormonal effects include: hypersecretion from the adenoma itself and hyposecretion from surrounding cells. The adenomatous tissue secretes the hormone of the cell type from which it arose, without regard to the needs of the body and w/o benefit of CLINICAL MANIFESTIONS: Increase in size causes headache, fatigue, neck pain or stiffness, and seizures. ● Visual changes ● Neuromuscular function ● Increase secretion of GH and prolactin ● Menstrual irregularity ● Decreased libido ● Receding secondary sex characteristics in both male and female. ● Thyroid and adrenal hypofunction bc of lack of TSH and ACTH=hypothyroidism and hypocortisolism. Hypersecretion of GH: Acromegaly results from high levels of GH and IGF- atherosclerosis, diabetes mellitus, or malignancy. PATHO: In children and adolescents whose epiphyseal plates have not yet closed, the effect of increased GH levels is termed Giatism. In the adult, increase amounts of GH and IGF-1 cause connective tissue proliferation and increased cytoplasmic matrix as well as bony proliferation that results in the characteristic appearance of acromegaly. Hyperglycemia results from GH’s inhibition of peripheral glucose uptake and increased hepatic glucose production, followed by compensatory hyperinsulinism and finally, insulin resistance. Diabetes occurs when the pancreas can’t secrete enough insulin to offset the effects of GH. Hypertension and left ventricular heart failure are seen. CLINICAL MANIFESTATIONS: Enlarged tongue ● Interstitial edema ● Overactive sebaceous and sweat glands ● Coarse skin and body hair ● Enlargement of the bones of the face, hands and feet. ● Barrel-chested (increased IGF-1) ● Weakness ● Muscular atrophy ● Foot drop, sensory changes in hands ● Diabetes symptoms Prolactinoma: most common hormonally active pituitary tumors. PATHO: Sustained increases in levels of serum prolactin. Elevated levels in women lead to amenorrhea, nonpuerperal mil production, hirsutism and osteopenia. Men=hypogonadism and erectile dysfunction. CLINICAL MANIFESTATIONS: ● Amenorrhea ● Hirsutism ● Osteoporosis ● Headache and visual impairment (men) ALTERATIONS OF THYROID FUNCTION: Develop as a result of primary dysfunction or disease of the thyroid gland or secondarily as a result of pituitary or hypothalamic alterations. Primary thyroid disorders- alterations of TH levels with secondary feedback effects on pituitary TSH. Primary elevations in TH level, TSH level will secondarily decrease bc of negative feedback. When TH level is decreased bc of condition affecting the thyroid gland, TSH level will be elevated. 1) Hyperthyroidism: Excess amounts of TH are secreted from the thyroid gland. It is a form of thyrotoxicosis-results from increased levels of TH. CLINICAL MANIFESTATIONS: FIG 18-6 Primary hyperthyroidism-caused by common diseases such as: Graves’ disease, toxic multinodular goiter, and solitary toxic adenoma. A. Graves’ disease: Autoimmune, type II hypersensitivity in which there is stimulation of the thyroid by autoantibodies (TSIs) directed against the TSH receptor, which override the normal regulatory mechanisms. Clinical Manifestations: Exophthalmos (orbital fat accumulation, inflammation, and edema of the orbital contents. Periorbital edema, extraocular muscle weakness leads to diplopia. ● Irritation ● Pain ● Lacrimation ● Photophobia ● Blurred vision/visual field impairment ● Decreased visual acuity ● Papilledema ● Exposure keratosis ● Corneal ulceration Graves dermopathy: very high levels of TSH. ● Subcutaneous swelling on anterior portions of legs and by indurated and erythematous skin. B. Toxic multinodular goiter: occurs when there are several hyperfunctioning nodules leading to hyperthyroidism. One nodule hyperfunctioning=toxic adenoma. C. Thyrotoxic crisis: usually occurs in those with undiagnosed or partially treated Graves’ disease and subjected to excessive stress, (ie) infection, pulmonary or cardio disorders, trauma, seizures, emotional stress, dialysis, plasmapheresis, or inadequate preparation for thyroid sx. S/S: hyperthermia, tachycardia, high-output heart failure, agitation, delirium, N/ V/D contributing to fluid volume depletion. 2) HYPOTHYROIDISM: Deficient production of TH by the thyroid gland. Most common. FIG 18-9! PATHO: Primary vs. Secondary Primary: loss of thyroid function leads to decreased production of TH and increased secretion of TSH and TRH. Common causes: autoimmune thyroiditis (Hashimoto disease), iatrogenic loss of thyroid tissue after surgical or radioactive treatment for hyperthyroidism or after head and neck radiation therapy, medications, endemic iodine deficiency. Secondary (central): caused by the pituitary’s failure to synthesize adequate amounts of TSH or a lack of TRH. Common causes: pituitary tumors compressing surrounding pituitary cells or the consequences of their treatment, traumatic brain injury, subarachnoid hemorrhage, or pituitary infarction. CLINICAL MANIFESTATIONS: Lowers energy metabolism ● Low basal metabolic rate ● Cold intolerance ● Lethargy ● Slightly lowered basal body temp ● Goiter- caused by decrease THexcessive TSH production stimulating thyroid tissue ● Myxedema-severe or long-standing hypothyroidism. ALTERATIONS OF PARATHYROID FUNCTION Hyperparathyroidism- Greater than normal secretion of PTH and hypercalcemia. PATHO: Primary: inappropriate excess secretion of PTH by one or more of the parathyroid glands. Majority cases caused by parathyroid adenomas. Other causes include parathyroid hyperplasia and parathyroid carcinoma and genetics. Secondary: compensatory response of the parathyroid glands to chronic hypocalcemia, which can be associated with decreased renal activation of Vit D. PTH can’t achieve normal calcium levels bc of insufficient levels of activated Vit D. Other causes include: dietary deficiency in Vit D or calcium, decreased intestinal absorption of Vit D or calcium, ingestion of drugs such as phenytoin, phenobarbital, and laxatives. CLINCIAL MANIFESTATIONS: Tetany presentation ● Fatigue ● Headache ● Depression ● Anorexia ● N/V ● Hypocalcemia (metabolic acidosis and production of an abnormally alkaline urine) and hypophosphatemia (PTH hypersecretion enhances renal phosphate excretion) ● Pathologic fx’s kyphosis of the dorsal spine and compression fx’s due to excessive osteoclast and osteocytic activity. Hypoparathyroidism: Abnormally low PTH levels most commonly caused by damage to the parathyroid glands, during thyroid sx. Also associated with genetic syndromes, including familial hypoparathyroidism and DiGeorge syndrome. PATHO: A lack of circulating PTH causes depressed serum calcium levels and increased serum phosphate levels. In the absence of PTH, reabsorption of calcium from bone and regulation of calcium reabsorption form the renal tubules are impaired. Phosphate reabsorption by the renal tubules is increased causing hyperphosphatemia. CLINICAL MANIFESTATIONS: Tetany ● Chvostek sign- tapping the cheek, resulting in twitching in upper lip. ● Trousseau sign-elicited by sustained inflammation of a bp machine placed on the upper arm to a level above the systolic bp with resultant painful carpal spasm. ● Dry skin ● Hair loss ● Hypoplasia of developing teeth ● Horizontal ridges on nails ● Bones deformity ● Cataracts ALTERATIONS OF ADRENAL FUNCTION Cushing syndrome: Excess cortisol (hypercortisolism). PATHO: 1) Normal diurnal or circadian secretion patterns of ACTH and cortisol are lost. 2) There is no increase in ACTH and cortisol secretions in response to a stressor. ACTH-dependent hypercortisolism, the excess ACTH stimulates excess production of cortisol and there is loss of feedback control of ACTH secretion. ACTH-independent hypercortisolism is caused by cortisol secretion from a rare benign or malignant tumor of one or both adrenal glands. CLINICAL MANIFESTIONS: ● Wheight gain ● Moon face ● Buffalo hump ● Supraclavicular fat pad ● Purple striae ● Pendulous abdomen Hyperaldosteronism: Excessive aldosterone secretion by the adrenal glands. Primary: Caused by excessive secretion of aldosterone from an abnormality of the adrenal cortex. PATHO: Increased renal sodium and water reabsorption with corresponding hypovolemia and hypertension, 2) renal excretion of potassium. Secondary: Extra-adrenal stimulus of aldosterone secretion, most often angiotensin II through a renin-dependent mechanism. Occurs in decreased circulating blood volume and decreased delivery of blood to kidney. Other causes: Bartter syndrome (renal tubular defect leading to hypokalemia and renin-secreting tumors of the kidney. PATHO: Potassium secretion is promoted by aldosterone, therefore; with excessive aldosterone, hypokalemia occurs. Hypokalemic alkalosis, changes in myocardial conduction, and skeletal muscle alterations may be seen. Renal tubules may become insensitive to ADH, promoting excessive water loss and in this situation hypernatremia also may occur because water is not able to follow the sodium that is reabsorbed. CLINICAL MANIFESTIONS: ● Hypertension (left ventricular dilation and hypertrophy and progressive arteriosclerosis) ● Hypokalemia ADRENOCORTICAL HYPOFUNCTION Hypocortisolism develops because of either inadequate simulation of the adrenal glands by ACTH or a primary inability of the adrenals to produce and secrete the adrenocortical hormones. Addison’s Disease: Autoimmune mechanisms that destroy adrenal cortical cells and more common in women. PATHO: Inadequate corticosteroid and mineralocorticoid synthesis and elevated levels of ACTH. CLINICAL MANIFESTIONS: ● Weakness ● Easy fatigability ● Hyperpigmentation ● Anorexia ● N/V/D ● Hypotension which can progress to complete vascular shock and collapse.
Información del documento
- Subido en
- 13 de junio de 2022
- Número de páginas
- 42
- Escrito en
- 2021/2022
- Tipo
- Otro
- Personaje
- Desconocido